Text Size
20 studies found for:    " July 25, 2007":" August 24, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" July 25, 2007":" August 24, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
Condition: HIV Infections
Interventions: Other: Behavioral counseling;   Device: HIV-1 Antibody Test Kit
2 Completed Kaletra Monotherapy in HIV/HCV Co-infected Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra Tablets
3 Unknown † Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
4 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
5 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
6 Completed Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
Condition: HIV Infections
Intervention:
7 Completed Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Condition: HIV Infections
Interventions: Drug: matching placebo;   Drug: Bevirimat
8 Completed DDI HV (ATV - Merck)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Drug: Atazanavir + Raltegravir
9 Active, not recruiting Autologous Dendritic Cell Vaccine in HIV1 Infection
Condition: HIV Infections
Intervention: Biological: Autologous HIV-1 ApB DC Vaccine
10 Unknown † Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
Conditions: HIV Infections;   Cancer, Second Primary
Interventions: Dietary Supplement: Probiotic Yogurt B: with various micronutrients;   Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients;   Dietary Supplement: Probiotic yogurt C: with basic micronutrients;   Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients
11 Completed
Has Results 		Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518);   Drug: Placebo
12 Unknown † Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
Conditions: Depression;   HIV Infection
Intervention: Behavioral: Cognitive behavioral therapy (CBT)
13 Completed Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
Condition: HIV Infections
Intervention: Drug: Pyridostigmine tablets
14 Terminated
Has Results 		Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
15 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
16 Completed Intervention for Newly Diagnosed Youth With HIV
Condition: HIV
Intervention: Behavioral: "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
17 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
18 Withdrawn Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
Conditions: AIDS-related Kaposi Sarcoma;   Classic Kaposi Sarcoma
Interventions: Drug: sunitinib malate;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study
19 Completed Lufwanyama Neonatal Survival Project
Condition: Mortality
Interventions: Other: Neonatal resuscitation protocol;   Other: Standard of care
20 Unknown † Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neurotoxicity;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Other: placebo
To Top

† Indicates status has not been verified in more than two years